Augmenting corneal thickness with FDA-approved hypotonic riboflavin

Video
Conference|SECO

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.

See more conference coverage

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Related Content
Shovlin's detailed key points from his presentation, including the increased toxicity from targeted immunotherapies like CAR T-cell therapy and checkpoint inhibitors, which often require careful management to avoid vision-threatening complications.

AOA 2025: Ocular toxicities in cancer patients – A Q&A with Dr Joe Shovlin

Jordana Joy, Associate Editor
August 8th 2025
Article
Optometry Times You and Eye

You and Eye: Undergoing EVO ICL vision correction as an eye care professional - with Jessica Vaidya, OD

Miriam Korik, OD;Jessica Vaidya, OD;Emily Kaiser Maharjan, Assistant Managing Editor
August 8th 2025
Podcast
Currently, 26.6 million people in Latin America are visually impaired.

AOA 2025: Optometry and visual impairment in Latin America

Jordana Joy, Associate Editor
August 8th 2025
Article
Debunking common ortho-k myths

Debunking common ortho-k myths

Kassi Filkins, Editor;Chandra Mickles, OD, MS, FAAO, FSLS
August 8th 2025
Podcast
While diabetic retinopathy is not one of the leading causes of blindness and vision impairment globally, the widespread prevalence of diabetes warrants the need for resources.

AOA 2025: What role do optometrists play in the diabetic pandemic?

Jordana Joy, Associate Editor
August 8th 2025
Article
The AOA president and Board of Trustees being sworn in during the House of Delegates meeting in Minneapolis, Minnesota. Image credit: American Optometric Association

AOA inducts new Board of Trustee members, Dr Jacqueline Bowen as president

Jordana Joy, Associate Editor
August 8th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.